News
HTFL
49.17
+1.05%
0.51
Heartflow Is Maintained at Buy by Canaccord Genuity
Dow Jones · 5d ago
Heartflow Price Target Raised to $56.00/Share From $45.00 by Canaccord Genuity
Dow Jones · 5d ago
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56
Benzinga · 5d ago
Heartflow price target raised to $56 from $45 at Canaccord
TipRanks · 5d ago
Biotech Stocks At 52-Week Highs - HSCS +7%, FRNM +5%, VOGX, HTFL, HALO
NASDAQ · 6d ago
Weekly Report: what happened at HTFL last week (0914-0918)?
Weekly Report · 6d ago
10 mid-cap healthcare stocks with the strongest momentum grades
Seeking Alpha · 09/17 14:10
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
The Motley Fool · 09/15 19:56
Weekly Report: what happened at HTFL last week (0907-0911)?
Weekly Report · 09/14 09:00
William Blair Sticks to Its Buy Rating for HeartFlow, Inc. (HTFL)
TipRanks · 09/12 03:55
Heartflow Price Target Announced at $55.00/Share by UBS
Dow Jones · 09/09 13:32
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55
Benzinga · 09/09 13:22
Heartflow initiated with a Neutral at UBS
TipRanks · 09/09 11:21
Weekly Report: what happened at HTFL last week (0831-0904)?
Weekly Report · 09/07 09:00
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The Motley Fool · 09/06 06:11
Baron SMID Cap ETF Q2 2026 Portfolio Activity
Seeking Alpha · 09/04 15:10
Weekly Report: what happened at HTFL last week (0824-0828)?
Weekly Report · 08/31 09:00
Heartflow FFRCT Cuts Unnecessary Invasive Heart Procedures 44% In FUSION Trial
NASDAQ · 08/28 18:07
These ten healthcare stocks posted the biggest gains over the past month
Seeking Alpha · 08/28 11:54
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
Barchart · 08/28 01:48
More
Webull provides a variety of real-time HTFL stock news. You can receive the latest news about HEARTFLOW INC through multiple platforms. This information may help you make smarter investment decisions.
About HTFL
Heartflow, Inc. is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). Its novel Heartflow Platform uses AI and advanced computational fluid dynamics to create a personalized 3D model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Heartflow RoadMap Analysis, Heartflow FFRCT Analysis, Heartflow Plaque Analysis and Heartflow PCI Navigator. Its Heartflow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. Heartflow RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review. Heartflow FFRCT Analysis calculates blood flow and pinpoints clinically significant CAD.